To confirm the role CHK1 plays in the synergistic antitumor interactions between panobinostat and the standard chemotherapeutic drugs, we treated neuroblastoma cells with the CHK1-specific inhibitor LY2603618. Here, CHEK1 is linked to neuroblastoma.